Mario Balsa/X
Jul 5, 2025, 19:42
Mario Balsa: TIME May Not Just Tell the Story – It Could Write the Prognosis STAR-01 at ESMOGI25
Mario Balsa, Medical Oncology Resident at Catalan Institute of Oncology (ICO), shared on X:
“STAR-01 at ESMOGI25: tumor immune microenvironment (TIME) and survival in LARC after pre-op CRT
303 pts | 110 paired samples
- High post-CRT CD20+, TILs and low CD4/CD8 → improved EFS and OS
- CD20+ cells ≥1% pre-CRT trended with better 5y-EFS (HR 0.59; p=0.051)
TIME may not just tell the story – it could write the prognosis.”
More posts featuring ESMOGI25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 16:53
Jul 27, 2025, 16:04
Jul 27, 2025, 15:38
Jul 27, 2025, 15:14